Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
0.8441
+0.0562 (7.13%)
At close: Apr 28, 2025, 4:00 PM
0.8370
-0.0071 (-0.84%)
After-hours: Apr 28, 2025, 7:08 PM EDT
Plus Therapeutics Employees
Plus Therapeutics had 21 employees as of December 31, 2024. The number of employees increased by 1 or 5.00% compared to the previous year.
Employees
21
Change (1Y)
1
Growth (1Y)
5.00%
Revenue / Employee
$277,333
Profits / Employee
-$618,000
Market Cap
14.35M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
PSTV News
- 5 days ago - Plus Therapeutics Announces Biotech Industry Veteran Kyle Guse Joins its Board of Directors - GlobeNewsWire
- 13 days ago - Plus Therapeutics Presents New Data Highlighting Clinical Benefit and Safety of REYOBIQ in the ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases - GlobeNewsWire
- 4 weeks ago - Plus Therapeutics, Inc. (PSTV) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Plus Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 5 weeks ago - Plus Therapeutics Introduces REYOBIQ™, FDA-Accepted Proprietary Name for Lead Drug Candidate - GlobeNewsWire
- 5 weeks ago - Plus Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 27, 2025 - GlobeNewsWire
- 6 weeks ago - D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq:PSTV) in Connection with its up to $15.0 Million Private Placement - Accesswire
- 7 weeks ago - Plus Therapeutics Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirement - GlobeNewsWire